Showing results (71-80 of 83) with videos related to
Sort By:
Pageof 9
Frontiers in Cell and Developmental Biology|June 1, 2022
Förster Resonance Energy Transfer-Based Single-Cell Imaging Reveals Piezo1-Induced Ca2+ Flux Mediates Membrane Ruffling and Cell SurvivalHeon-Su Kim, Jung-Soo Suh, Yoon-Kwan Jang, et al.Biomolecules & Therapeutics|April 11, 2024
Morroniside Protects C2C12 Myoblasts from Oxidative Damage Caused by ROS-Mediated Mitochondrial Damage and Induction of Endoplasmic Reticulum StressHyun Hwangbo, Cheol Park, EunJin Bang, et al.Hepatology (Baltimore, Md.)|June 26, 2010
Activation of Rac1 promotes hedgehog-mediated acquisition of the myofibroblastic phenotype in rat and human hepatic stellate cellsSteve S Choi, Rafal P Witek, Liu Yang, et al.The Journal of Clinical Investigation|September 20, 2008
Hedgehog signaling regulates epithelial-mesenchymal transition during biliary fibrosis in rodents and humansAlessia Omenetti, Alessandro Porrello, Youngmi Jung, et al.Hepatology (Baltimore, Md.)|August 14, 2009
Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitisRafal P Witek, W Carl Stone, F Gamze Karaca, et al.Gastroenterology|July 7, 2009
Hedgehog-mediated epithelial-to-mesenchymal transition and fibrogenic repair in nonalcoholic fatty liver diseaseWing-Kin Syn, Youngmi Jung, Alessia Omenetti, et al.Hepatology (Baltimore, Md.)|June 1, 2010
Accumulation of natural killer T cells in progressive nonalcoholic fatty liver diseaseWing-Kin Syn, Ye Htun Oo, Thiago A Pereira, et al.Medcomm|October 29, 2025
Benzoxazole Derivatives as Potent FXR and PPARα Dual Agonists With Anti-Fibrotic and Metabolic Regulatory EffectsMi-Jeong Kim, Dong-Gyun Han, Hyeon Seo Park, et al.Laboratory Investigation; a Journal of Technical Methods and Pathology|August 11, 2010
Viral factors induce Hedgehog pathway activation in humans with viral hepatitis, cirrhosis, and hepatocellular carcinomaThiago de Almeida Pereira, Rafal P Witek, Wing-Kin Syn, et al.Plos One|September 14, 2011
Hedgehog signaling antagonist promotes regression of both liver fibrosis and hepatocellular carcinoma in a murine model of primary liver cancerGeorge M Philips, Isaac S Chan, Marzena Swiderska, et al.Pageof 9